MY170724A - Use of certain trioxygenated benzene derivatives in body fat management - Google Patents

Use of certain trioxygenated benzene derivatives in body fat management

Info

Publication number
MY170724A
MY170724A MYPI2014001278A MYPI2014001278A MY170724A MY 170724 A MY170724 A MY 170724A MY PI2014001278 A MYPI2014001278 A MY PI2014001278A MY PI2014001278 A MYPI2014001278 A MY PI2014001278A MY 170724 A MY170724 A MY 170724A
Authority
MY
Malaysia
Prior art keywords
body fat
certain
trioxygenated
formula
benzene derivatives
Prior art date
Application number
MYPI2014001278A
Inventor
K George Annie George V
Matthias Gehling
Torsten Grothe
Jens Bitzer
Barbel Kopcke
Ingo Wohrle
Sasikala Chinnappan
Akir Mazria Haslina Md
Original Assignee
Biotropics Malaysia Berhad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotropics Malaysia Berhad filed Critical Biotropics Malaysia Berhad
Publication of MY170724A publication Critical patent/MY170724A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The invention primarily relates to the use of certain trioxygenated benzene derivatives of formula (I) or a corresponding plant extract as body fat modulating agents, preferably as anti-cellulite actives and/or for the reduction of the body fat content, in particular for reduction of body weight and/or for the management of obesity. The present invention also relates to corresponding methods and to certain novel compounds of formula (I). The invention further relates to specific plant extract formulations obtainable from plant roots of Labisia pumila, and to compositions, in particular cosmetic or pharmaceutical formulations, comprising an effective amount of one or more compounds of formula (I) or of a corresponding plant extract formulation.
MYPI2014001278A 2012-01-27 2012-01-27 Use of certain trioxygenated benzene derivatives in body fat management MY170724A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MY2012/000008 WO2013112040A1 (en) 2012-01-27 2012-01-27 Use of certain trioxygenated benzene derivatives in body fat management

Publications (1)

Publication Number Publication Date
MY170724A true MY170724A (en) 2019-08-27

Family

ID=45688211

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2014001278A MY170724A (en) 2012-01-27 2012-01-27 Use of certain trioxygenated benzene derivatives in body fat management

Country Status (2)

Country Link
MY (1) MY170724A (en)
WO (1) WO2013112040A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY193591A (en) * 2014-12-08 2022-10-19 Kementerian Pertanian & Ind Asas Tani Standardised extract of labisia pumila for weight reduction and nano-formulation thereof
CN106562939B (en) * 2015-10-08 2019-01-15 中国科学院微生物研究所 Application of compound AJ-4 in preparing medicine for treating or preventing influenza virus
MY183077A (en) * 2016-08-01 2021-02-10 Univ Kebangsaan Malaysia A process for extracting irisresorcinol from labisia pumila
US12403166B2 (en) 2021-11-02 2025-09-02 Medika Natura Sdn. Bhd. Labisia pumila extract composition and its pharmaceutical formulation

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352690A (en) 1992-07-01 1994-10-04 Eli Lilly And Company 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists
JP2002503202A (en) * 1996-02-02 2002-01-29 メルク エンド カンパニー インコーポレーテッド Antidiabetic drugs
US6530886B1 (en) 1999-10-08 2003-03-11 Tanita Corporation Method and apparatus for measuring subcutaneous fat using ultrasonic wave
DE10009423A1 (en) 2000-02-28 2001-09-06 Henkel Kgaa Cosmetic or pharmaceutical preparation especially for treatment of cellulite comprises nerve fibre stimulator or depolariser, phosphodiesterase inhibitor and antiestrogen
ES2233630T3 (en) 2000-04-12 2005-06-16 Bitop Aktiengesellschaft Fur Biotechnische Optimierung USE OF COMPATIBLE SOLUTES AS SUBSTANCES WITH RADICAL SWEEPING PROPERTIES.
AU2001295469A1 (en) 2000-08-18 2002-03-04 Bitop Gesellschaft Fur Biotechnische Optimierung Mbh Cosmetic formulation containing at least one di-sugar alcohol phosphate of c3 to c6 sugar alcohols
EP1234572B1 (en) 2001-02-26 2013-10-30 Mibelle AG Cosmetics Skin treatment compositions containing isoflavone aglycones
DE10254872A1 (en) 2002-11-25 2004-06-03 Symrise Gmbh & Co. Kg Anthranilic acid amides and their derivatives as cosmetic and pharmaceutical active ingredients
KR100572621B1 (en) 2003-03-19 2006-04-24 한국 한의학 연구원 Compositions for the treatment of obesity and adult diseases
WO2004096252A1 (en) 2003-04-25 2004-11-11 Primavera Biosciences, Inc. Compositions and methods for weight loss
EP1648403B1 (en) 2003-05-20 2012-08-15 Sederma Slimming cosmetic composition comprising cafestol or kahweol
ATE415976T1 (en) 2004-06-18 2008-12-15 Symrise Gmbh & Co Kg BLACKBERRY EXTRACT
AU2005298653A1 (en) 2004-10-25 2006-05-04 Symrise Gmbh & Co. Kg Use of glycosylated flavanones for the browning of skin or hair
US20100286102A1 (en) 2004-11-22 2010-11-11 Symrise Gmbh & Co. Kg Formulations comprising ceramides and/or pseudoceramides and (alpha-)bisabolol for combating skin damage
KR20070086101A (en) 2004-12-14 2007-08-27 메나리니 리케르체 에스.피.아. Pharmaceutical composition for treating cellulite
MY147497A (en) 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
EP1937366B1 (en) 2005-10-14 2011-12-14 Symrise AG Synergistic mixtures of bisabolol and ginger extract
FR2895676B1 (en) 2006-01-04 2011-05-27 Sederma Sa COSMETIC COMPOSITION CONTAINING GLAUCIN AND USE THEREOF
WO2007110415A2 (en) 2006-03-27 2007-10-04 Symrise Gmbh & Co. Kg Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds
WO2007116579A1 (en) 2006-04-07 2007-10-18 Kao Corporation Lypolysis promoter
DE102006043587A1 (en) 2006-09-16 2008-03-27 Symrise Gmbh & Co. Kg 2-methyl-2-alkenyl-substituted 1,3-dioxanes as fragrances
EP1915982A1 (en) 2006-10-20 2008-04-30 Symrise GmbH & Co. KG Use of 1,2-decanediol for reducing sebum concentration and/or for enhancing penetration of actives into skin areas, and cosmetic and/or dermatological compositions comprising 1,2-decanediol
DE102006050398A1 (en) 2006-10-20 2008-04-24 Henkel Kgaa Cosmetic agent containing purine and / or purine derivative and taurine
EP1923041A1 (en) 2006-10-20 2008-05-21 Symrise GmbH & Co. KG Use of C10-C14 alkane diols for the preparation of a composition for the prophylaxis and/or treatment of Malassezia-induced dandruff, and compositions comprising C10-C14 alkane diols
EP2025335A1 (en) 2007-08-16 2009-02-18 InterMed Discovery GmbH Extracts with liver-X-receptor modulators, compounds and their use in weight control and treatment of disorders of lipid metabolism
WO2009064155A1 (en) 2007-11-15 2009-05-22 Holista Biotechnology Sdn Bhd Immunopotentiating composition from labisia pumila extract
WO2009064156A1 (en) 2007-11-15 2009-05-22 Holista Biotechnology Sdn Bhd Novel composition obtained from labisia pumila extract for hepatoprotective activity
MY151834A (en) 2008-03-19 2014-07-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia A standardised aqueous extract of labisia pumila
KR101007252B1 (en) 2008-04-28 2011-01-13 주식회사 엘씨에스바이오텍 Cosmetic composition comprising a fermentation extract of Ravigian fumila, pharmaceutical composition
US20130078323A1 (en) 2009-06-16 2013-03-28 Holista Biotech Sdn. Bhd. Adaptogenic activity of labisia pumila extract

Also Published As

Publication number Publication date
WO2013112040A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
MX362655B (en) Cosmetic compositions.
MX357554B (en) Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects.
NZ702472A (en) Oil/water-emulsion-type topical compositions containing a retinoid
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
WO2011149301A3 (en) A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
MX342119B (en) Substituted 2-oxy-quinoline-3-carboxamides as kcnq2/3 modulators.
MX2014014517A (en) Topical compositions in the form of a gel containing a particular solubilised retinoid.
MY170724A (en) Use of certain trioxygenated benzene derivatives in body fat management
MX2010001693A (en) Sprayable composition containing red vine leaf extract.
MX2012013642A (en) Topical pharmaceutical compositions comprising mometasone furoate.
MX2014014579A (en) O/w-emulsion-type topical pharmaceutical compositions containing a retinoid.
IN2014DN09584A (en)
MX359955B (en) Flavor and fragrance formulation (iii).
MX365429B (en) Flavor and fragrance formulation (i).
WO2012108747A3 (en) Composition and cosmetic composition for treating brain cancer comprising helena root extract
MX2013002295A (en) Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators.
MX360017B (en) Flavor and fragrance formulation (iv).
MX358797B (en) Flavor and fragrance formulation (vi).
WO2012077976A3 (en) Anti-aging composition containing elaeocarpus petiolatus extract or fraction thereof as active ingredient
WO2012001293A3 (en) Cosmetic composition for the nails and use of an isosorbide derivative
WO2012108745A3 (en) Composition and health functional food for treating brain cancer comprising gleditsiae semen extract
WO2012108744A3 (en) Composition and health functional food for treating brain cancer comprising inula flower extract
WO2012047007A3 (en) Composition for promoting fingernail or toenail growth
WO2012108743A3 (en) Composition and cosmetic composition for treating brain cancer comprising white pharbitis seed extract